# FDA Inspection 1165234 - MGH Bone Bank - March 02, 2022

Source: https://www.keypedia.com/records/fda_inspections/mgh-bone-bank/e4e026b0-defa-415c-859e-df8cc35d4b50
Source feed: FDA_Inspections

> FDA Inspection 1165234 for MGH Bone Bank on March 02, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165234
- Company Name: MGH Bone Bank
- Inspection Date: 2022-03-02
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1165234 - 2022-03-02](https://www.keypedia.com/records/fda_inspections/mgh-bone-bank/3a014615-717d-453e-8bc1-df30bf233e71)
- [FDA Inspection 1000064 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/mgh-bone-bank/b4efb483-ee36-437a-97cb-c2e3c3445112)
- [FDA Inspection 870249 - 2014-03-06](https://www.keypedia.com/records/fda_inspections/mgh-bone-bank/9e155d14-0807-4904-82a3-30f460058383)

Company: https://www.keypedia.com/companies/mgh-bone-bank/4319eeec-d601-4857-9b2b-a000baa354d5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d